[1]孙钺,肖践明.冠状动脉支架的历史发展与未来展望[J].心血管病学进展,2016,(1):23-27.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.007]
　SUN Yue,XIAO Jianming.Historical Development and Future Prospects of Coronary Artery Stents[J].Advances in Cardiovascular Diseases,2016,(1):23-27.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.007]
点击复制

冠状动脉支架的历史发展与未来展望()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2016年1期
页码:
23-27
栏目:
综述
出版日期:
2016-02-20

文章信息/Info

Title:
Historical Development and Future Prospects of Coronary Artery Stents
作者:
孙钺; 肖践明
昆明医科大学第一附属医院心脏内科,云南 昆明 650032
Author(s):
SUN Yue;  XIAO Jianming
Department of Cardiology,The First Affiliated Hospital of Kunming Medical University,Kunming 650032,Yunnan,China
关键词:
冠状动脉支架;  冠心病;  未来展望
Keywords:
Coronary artery stents;  Coronary heart disease;  Perspectives
分类号:
R541.4; R318.1
DOI:
10.16806/j.cnki.issn.1004-3934.2016.01.007
文献标志码:
A
摘要:
心脏冠状动脉支架是治疗冠心病的重要器材。冠状动脉支架的产生以及发展显著影响了临床对冠心病治疗的效果与预后。现介绍冠状动脉支架的发展历史与未来展望并阐述其对冠心病临床治疗的相关影响。
Abstract:
Heart coronary artery stents is important equipment for the treatment of coronary heart disease. The production and development of coronary artery stent significantly influence the clinical effect and prognosis of coronary heart disease treatment. This paper introduces the development history and future outlook of coronary stents and its related impact on the clinical treatment of coronary heart disease.

参考文献/References:

[1] Roger VL,Go AS,Lloyd-Jones DM,et al.Heart disease and stroke statistics—2012 update:a report from the American Heart Association[J].Circulation,2012,125(22): e1002.
[2] 陈伟伟,高润霖,李莹,等.卫生部心血管病防治研究中心:中国心血管病报告2011[R].北京:中国大百科全书,2011:4-6.
[3] 李田昌.冠心病介入治疗现状[J].中国全科医学,2007,10(16):1317-1320.
[4] 谭永智.美国心血管介入治疗器械市场介绍[EB/OL]. http://md.tech-ex.com/2012/article_0101/17361.html,2012-01-01.
[5] Henry M. State of the art:which stent for which lesion in peripheral interventiongs?[J].Tex Heart Inst J,2000,27(2):199-126.
[6] 张茵. 生物及金属可降解支架在冠状动脉粥样硬化性心脏病介入治疗中的研究进展[J]. 心血管病学进展,2013,34(1):38-41.
[7] 马丽娟,高明宇. 冠状动脉支架材料与炎症反应[J].中国组织工程研究与临床康复,2010,14(21):3887-3890.
[8] 徐海峰. 血管内支架表面生物涂层材料与血管内再狭窄[J]. 中国组织工程研究与临床康复,2011,15(51):9667-9670.
[9] Garg S, Bourantas C, Serruys PW.New concepts in the design of drug-eluting coronary stents[J]. Nat Rev Cardiol,2013,10(5):248-260.
[10] 董思远.心脏支架材料的比较应用研究[J].中国药物警戒,2012,9(12):728-730.
[11] 何国祥. 生物可降解冠状动脉支架研究进展[J].遵义医学院学报,2014,37(2): 125-131.
[12] Muramatsu T, Onuma Y, Zhang YJ,et al. Progress in treatment by percutaneous coronary intervention:the stent of the future[J]. Rev Esp Cardiol,2013,66(6):483-496.
[13] Neamtu I, Chiriac AP, Diaconu A, et al.Current concepts on cardiovascular stent devices[J]. Mini Rev Med Chem,2014,14(6):505-536.
[14] Zhang Y, Bourantas CV, Farooq V,et al. Bioresorbable scaffolds in the treatment of coronary artery disease[J]. Med Devices(Auckl),2013,6:37-48.
[15] 陈佳慧,沈雳,王齐兵,等. 冠状动脉生物可降解支架设计与应用:材料学的进一步革新将带来什么?[J]. 中国胸心血管外科临床杂志,2007,14(6):4878-4888.
[16] 席玉胜. 可降解心血管支架材料发展的优势与趋势[J]. 中国组织工程研究与临床康复,2010,14(34):6397-6400.
[17] Sammel AM,Chen D,Jepson BN,et al.New generation coronary stent technology—is the future biodegradable?[J].Heart Lung Circ,2013,22(7):495-506.
[18] Muramatsu T,Onuma Y,Zhang YJ,et al.Progress in treatment by percutaneous coronary intervention:the stent of the future[J]. Rev Esp Cardiol,2013,66(6):483-496.
[19] Gogas BD,Farooq V,Onuma Y,et al. The ABSORB bioresorbable vascular scaffold: an evolution or revolution in interventional cardiology?[J]. Hellenic J Cardiol,2012,53(4):301-309.
[20] 沈莹冉.生物可降解冠状动脉支架的研究进展[J]. 外科研究与新技术, 2014,3(4):267-274.
[21] Peuster M,Wohlsein P,Brügmann M,et al.Anovel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-8 months after implantationg into New Zealand white rabbits[J].Heart,2001,86(5):563-569.
[22] Peuster M, Hesse C, Schloo T, et al. Long-term biocompatibility of a corrodible peripheral iron stent in the porcine descending aorta[J]. Biomaterials,2006,27(28):4955-4962.
[23] Waksman R, Pakala R, Baffour R, et al. Short-term effects of biocorrodible iron stents in porcine coronary arteries[J].J Interv Cardiol,2008,21(1):15-20.
[24] Dudek D. Bioresorbable vascular scaffolds in patients with ACS—The multicenter registry in Poland:POLAR ACS[R].EuroPCR meeting,2013.
[25] van Geuns RJ. BVS Expand:first results of wide clinical applications of bioresorbable vascular scaffold[R].EuroPCR meeting,2013.
[26] 周力,孙颖,陈晖. 全吸收式生物可降解支架在冠心病介入治疗中的应用[J]. 中国介入心脏病学杂志,2014,22(4):262-264.
[27] 葛均波. 冠心病介入治疗的过去、现在和未来[J]. 遵义医学院学报,2014,37(l):1-5.

相似文献/References:

[1]田丁,张俊峰.心肌缺血早期诊断的无创检查方法进展[J].心血管病学进展,2016,(1):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
　TIAN Ding,ZHANG Junfeng.Review of Noninvasive Screening Methods Development in Early Diagnosis of Myocardial Ischemia[J].Advances in Cardiovascular Diseases,2016,(1):19.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.006]
[2]吴文芳,赵新湘,闫东.颈动脉斑块的核磁共振成像检测在冠心病中研究及应用进展[J].心血管病学进展,2016,(1):91.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.024]
　WU Wenfang,ZHAO Xinxiang,YAN Dong.Magnetic Resonance Imaging Detection of Carotid Artery Plaque in Coronary Artery Disease and Its Application[J].Advances in Cardiovascular Diseases,2016,(1):91.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.024]
[3]段兴连,综述,常静,等.阻塞性睡眠呼吸暂停低通气综合征及其干预治疗对心血管疾病的临床意义[J].心血管病学进展,2016,(3):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
　DUAN Xinglian,CHANG Jing.Clinical Significance of OSAHS and Its Intervention Therapy on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(1):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
[4]杨立华,综述,钟国强,等.经皮冠状动脉介入术后患者抑郁变化的研究进展[J].心血管病学进展,2016,(3):299.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.022]
　YANG Lihua,ZHONG Guoqiang.Advance in Change of Depression in Patients Receiving Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2016,(1):299.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.022]
[5]方颖,综述,张冬颖,等.被动吸烟与女性冠心病的研究进展[J].心血管病学进展,2016,(4):423.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.025]
　FANG Ying,ZHANG Dongying.Progress of Passive Smoking and Female Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(1):423.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.025]
[6]梅宝菲,孔一慧,李为民.睡眠障碍与心血管疾病研究新进展[J].心血管病学进展,2015,(5):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
　MEI Baofei,KONG Yihui,LI Weimin.Relationship Between Somnipathy and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(1):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
[7]喻晓菊,张敏,郭涛.5-羟色胺转运体启动子连锁多态区多态性与冠心病关系的研究进展[J].心血管病学进展,2015,(5):610.[doi:10.3969/j.issn.1004-3934.2015.05.022]
　YU Xiaoju,ZHANG Min,GUO Tao.Association Between Serotonin Transporter Gene-linked Polymorphic Region and Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(1):610.[doi:10.3969/j.issn.1004-3934.2015.05.022]
[8]于洋,田俊萍,杜凤和.动态心电图在冠心病中的应用价值[J].心血管病学进展,2015,(6):695.[doi:10.3969/j.issn.1004-3934.2015.06.010]
　YU Yang,TIAN Junping,DU Fenghe.Value of Ambulatory Electrocardiography in Diagnosis of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2015,(1):695.[doi:10.3969/j.issn.1004-3934.2015.06.010]
[9]赵淑丽,楚天舒.血浆致动脉硬化指数在冠心病中的应用及研究进展[J].心血管病学进展,2015,(6):721.[doi:10.3969/j.issn.1004-3934.2015.06.016]
　ZHAO Shuli,CHU Tianshu.Application and Research Progress of Atherogenic Index of Plasma in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2015,(1):721.[doi:10.3969/j.issn.1004-3934.2015.06.016]

备注/Memo

备注/Memo:
作者简介:孙钺(1987—),在读硕士,主要从事冠心病介入治疗研究。Email:85764189@qq.com
通信作者:肖践明(1959—),主任医师,教授,硕士研究生导师,硕士,主要从事冠心病介入诊疗研究。Email: jianmingxiao@163.com
更新日期/Last Update: 2016-02-20